HC Andersen Capital notes that Gubra hosts its R&D Event in London on 27 October, where the UCN2 development strategy, indication expansion, and the 2030 growth strategy are expected to be set out.

Public source

Publisher name

Public post

We have updated our One-pager investment case on Gubra to reflect a quarter in which the clinical picture changed materially. Both partnered obesity assets have moved in…

Log in to read the full post

Company

Discover more

Similar public activity from other companies.

Customize signals for your business.

Know everything happening across the B2B world, and act on the company movements that matter to you.

© 2026 SeedOpsCompany intelligence.

SeedOps.